NCT07093892 · NOT YET RECRUITING
Cohort Study on Cognitive Decline in Elderly
This is an observational study, not a drug test. Researchers near Peking University Third Hospital plan to follow older adults for three years. They will track memory and thinking tests and blood biomarkers to see who develops mild cognitive impairment or Alzheimer's. No intervention is being tested, and no phase is listed.
You may qualify if
- Aged 55 years or older;
- No diagnosis of Alzheimer's disease (AD);
- Participants are able to complete cognitive tests, provide biological samples, undergo neuroimaging examinations, and cooperate throughout the entire study process;
- Signed informed consent.
You're excluded if
- Participants with severe mental illness, tumor-related cachexia, severe hepatic or renal insufficiency, or other major physical conditions that may hinder cooperation with the examinations;
- Participants who are unable to complete the required assessments due to visual or hearing impairments;
- Contraindications for MRI or other study-related examinations.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-07-30